Endologix Announces Presentation of Data From PEVAR Randomized Trial

[at noodls] – IRVINE, Calif., Jan. 28, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that data from the first prospective, … more

View todays social media effects on ELGX

View the latest stocks trending across Twitter. Click to view dashboard

See who Endologix is hiring next, click here to view